Medical research

Existing drug may help fight the lethality of E. coli infection

Stopping the spread of Shiga toxins released by E. coli bacteria, which are potentially fatal if they reach the kidneys, has been a focus of researchers for years. No treatments for STEC currently exist, and antibiotic therapy ...

Diseases, Conditions, Syndromes

Fast-changing genetics key to hospital superbug survival

For the study, published today in Microbial Genomics, a team of scientists at UCL Genetics Institute and Peking University People's Hospital in Beijing tracked the spread of K. pneumoniae in a Beijing hospital following a ...

Diseases, Conditions, Syndromes

Oral antibiotics noninferior to IV for bone, joint infection

(HealthDay)—For patients being treated for bone or joint infection, oral antibiotics are noninferior to intravenous antibiotics, according to a study published in the Jan. 31 issue of the New England Journal of Medicine.

Pediatrics

Low recurrence with shortened IV abx course in GBS bacteremia

(HealthDay)—For infants with uncomplicated, late-onset group B Streptococcus (GBS) bacteremia, a shortened intravenous (IV) course of antibiotic therapy is sometimes prescribed and is associated with low rates of disease ...

Immunology

Gut fungus exacerbates asthma in antibiotic-treated mice

A non-pathogenic fungus can expand in the intestines of antibiotic-treated mice and enhance the severity of allergic airways disease, according to a study published September 20 in the open-access journal PLOS Pathogens by ...

Diseases, Conditions, Syndromes

Duration of antibiotics often exceeds guidelines for sinusitis

(HealthDay)—The durations of most courses of antibiotic therapy for adult outpatients with sinusitis exceed guideline recommendations, according to a research letter published online March 26 in JAMA Internal Medicine.

page 6 from 14